Fully Activated MEK1 Exhibits Compromised Affinity for Binding of Allosteric Inhibitors U0126 and PD0325901

Abstract

Kinases catalyze the transfer of γ-phosphate from ATP to substrate protein residues triggering signaling pathways responsible for a plethora of cellular events. Isolation and production of homogeneous preparations of kinases in their fully active forms is important for accurate in vitro measurements of activity, stability, and ligand binding properties of these proteins. Previous studies have shown that MEK1 can be produced in its active phosphorylated form by coexpression with RAF1 in insect cells. In this study, using activated MEK1 produced by in vitro activation by RAF1 (pMEK1(in vitro)), we demonstrate that the simultaneous expression of RAF1 for production of activated MEK1 does not result in stoichiometric phosphorylation of MEK1. The pMEK1(in vitro) showed higher specific activity toward ERK2 protein substrate compared to the pMEK1 that was activated via coexpression with RAF1 (pMEK1(in situ)). The two pMEK1 preparations showed quantitative differences in the phosphorylation of T-loop residue serine 222 by Western blotting and mass spectrometry. Finally, pMEK1(in vitro) showed marked differences in the ligand binding properties compared to pMEK1(in situ). Contrary to previous findings, pMEK1(in vitro) bound allosteric inhibitors U0126 and PD0325901 with a significantly lower affinity than pMEK1(in situ) as well as its unphosphorylated counterpart (npMEK1) as demonstrated by thermal-shift, AS-MS, and calorimetric studies. The differences in inhibitor binding affinity provide direct evidence that unphosphorylated and RAF1-phosphorylated MEK1 form distinct inhibitor sites.

Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography

“…Fluorescence signals were acquired with excitation and emission wavelengths of 490 and 560 nm, respectively. A customized analysis program using a non-linear least square method based on the generalized reduced gradient algorithm was used to fit the protein unfolding model (34). The following parameters were floated during the fitting process: y intercepts for the intensity of Sypro Orange in both the native and denatured proteins (y n and y d ); the associated slopes (M n and M d ); the midpoint of melting (T m ); and the enthalpy at the T m (⌬H m ).…”

MEK and the inhibitors: from bench to bedside

“…Transient and reversible visual effects characterized by blurred vision and halos were observed at ≥15 mg BID [89,90]. The most frequent treatment-emergent adverse events (TEAE) included rash, fatigue, diarrhea, nausea, and vomiting.…”

Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF–MEK–ERK Pathway in Cancer

“…As the MEK activation loop serines become phosphorylated by Raf, the affinity of MEK inhibitors decreases significantly for the allosteric regulatory site that they bind. When both activation loop serines are phosphorylated the affinity of MEK inhibitors for binding to the allosteric regulatory site is decreased by 20-fold (63, 64), effectively diminishing the potency of the inhibitors (Fig. 2).…”